Comparing Long-Term Outcomes of Entecavir and Tenofovir Disoproxil Fumarate in Liver Transplant Patients

<div>Cumulative incidence of HBV recurrence. (a) Cumulative incidence of HBV recurrence stratified by different antiviral agents before propensity score matching. (b) Cumulative incidence of HBV recurrence stratified by different antiviral agents after propensity score matching.</div>

Advanced Gut & Microbiome Research

fig4

Figure 4

Figure 4: Comparing Long-Term Outcomes of Entecavir and Tenofovir Disoproxil Fumarate in Liver Transplant Patients 